{
    "root": "35d3eb43-c6ef-f3ab-e063-6294a90a0891",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Zyclara",
    "value": "20250523",
    "ingredients": [
        {
            "name": "ISOSTEARIC ACID",
            "code": "X33R8U0062",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "CETYL ALCOHOL",
            "code": "936JST6JCN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "STEARYL ALCOHOL",
            "code": "2KR89I4H1Y",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "PETROLATUM",
            "code": "4T6H12BN9U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11058"
        },
        {
            "name": "POLYSORBATE 60",
            "code": "CAL22UVI4M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53425"
        },
        {
            "name": "SORBITAN MONOSTEARATE",
            "code": "NVZ4I0H58X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_183394"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_189560"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17987"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32063"
        },
        {
            "name": "IMIQUIMOD",
            "code": "P1QW714R7M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_36704"
        }
    ],
    "indications": {
        "text": "zyclara 2.5 % 3.75 % indicated topical treatment clinically typical , visible , palpable actinic keratoses ( ak ) face balding scalp immunocompetent adults . ( 1.1 ) zyclara , 3.75 % indicated topical treatment external genital perianal warts ( egw ) immunocompetent patients 12 years age older . ( 1.2 )",
        "doid_entities": [
            {
                "text": "face (DOID:0111084)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0111084"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "topical ; oral , ophthalmic , intra-anal intravaginal . ( 2.1 ) ak : apply thin layer daily bedtime affected area ( either entire face balding scalp ) two 2-week treatment cycles separated 2-week no-treatment period . apply 0.5 grams application . ( 2.2 ) egw : apply thin layer daily bedtime total clearance 8 weeks . apply 0.25 grams application . ( 2.3 )",
        "doid_entities": [
            {
                "text": "face (DOID:0111084)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0111084"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "supplied zyclara ( imiquimod ) cream white faintly yellow color . zyclara , 2.5 % 3.75 % supplied white plastic 30 ml pump bottles , equipped white cap . 7.5 g pump bottle delivers fewer 28 full actuations : 2.5 % cream , ndc 99207-276-75 3.75 % cream , ndc 99207-271-75 zyclara , 3.75 % also supplied unit-dose plastic laminate packets contain 0.25 g cream : 3.75 % cream , box 28 packets , ndc 99207-270-28",
    "adverseReactions": "none .",
    "indications_original": "ZYCLARA 2.5% and 3.75% is indicated for the topical treatment of clinically typical, visible, or palpable actinic keratoses (AK) of the face or balding scalp in immunocompetent adults. ( 1.1 ) ZYCLARA, 3.75% is indicated for the topical treatment of external genital and perianal warts (EGW) in immunocompetent patients 12 years of age or older. ( 1.2 )",
    "contraindications_original": "For topical use only; not for oral, ophthalmic, intra-anal or intravaginal use. ( 2.1 ) AK : Apply a thin layer once daily at bedtime to affected area (either entire face or balding scalp) for two 2-week treatment cycles separated by a 2-week no-treatment period. Apply up to 0.5 grams at each application. ( 2.2 ) EGW : Apply a thin layer once daily at bedtime until total clearance or up to 8 weeks. Apply up to 0.25 grams at each application. ( 2.3 )",
    "warningsAndPrecautions_original": "How Supplied\n                  \n                  ZYCLARA (imiquimod) cream is white to faintly yellow in color.\n                  ZYCLARA, 2.5% and 3.75% is supplied as white plastic 30 mL pump bottles, equipped with a white cap. The 7.5 g pump bottle delivers no fewer than 28 full actuations:\n                  \n                     2.5% cream, NDC 99207-276-75\n                     3.75% cream, NDC 99207-271-75\n                  \n                  ZYCLARA, 3.75% is also supplied in unit-dose plastic laminate packets which contain 0.25 g of cream:\n                  \n                     3.75% cream, box of 28 packets, NDC 99207-270-28",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Zyclara",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        }
    ]
}